Search research articles
Contact Us
Filters
Showing results (211-220 of 264) with videos related to
Page
of 27
Sort By:
JCO Precision Oncology
|
December 7, 2020
Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes
Evan Rosenbaum, Philip Jonsson, Kenneth Seier, et al.
Investigational New Drugs
|
August 14, 2018
A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
Ciara M Kelly, Alexander N Shoushtari, Li-Xuan Qin, et al.
The Journal of Clinical Investigation
|
January 24, 2018
COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors
Yuanyuan Xie, Zhen Cao, Elissa Wp Wong, et al.
The Oncologist
|
July 27, 2021
Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study
John R Zalcberg, Michael C Heinrich, Suzanne George, et al.
The Lancet. Oncology
|
July 8, 2024
Interpretable artificial intelligence to optimise use of imatinib after resection in patients with localised gastrointestinal stromal tumours: an observational cohort study
Dimitris Bertsimas, Georgios Antonios Margonis, Suleeporn Sujichantararat, et al.
Science Advances
|
April 5, 2023
ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer
Dan Li, Yu Zhan, Naitao Wang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
September 7, 2024
Comprehensive genomic profiling in multiple cancer types: A comparative analysis of the National Biobank Consortium of Taiwan and clinical practice cohorts
Ling-Jen Hung, Chen-Yang Huang, Kai-Che Tung, et al.
The Journal of Clinical Investigation
|
June 24, 2025
BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature-positive castration-resistant prostate cancer
Shipra Shukla, Dan Li, Woo Hyun Cho, et al.
Cancer Discovery
|
December 15, 2020
SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies
Mahesh Saqcena, Luis Javier Leandro-Garcia, Jesper L V Maag, et al.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
Cell-Autonomous AR Dependence in Luminal Prostatic Epithelium Governs Survival and Lineage Plasticity
Dan Li, Naitao Wang, Wangxin Guo, et al.
Page
of 27
Search research articles
Search
Showing results (211-220 of 264) with videos related to
Sort By:
Page
of 27
JCO Precision Oncology
|
December 7, 2020
Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes
Evan Rosenbaum, Philip Jonsson, Kenneth Seier, et al.
Investigational New Drugs
|
August 14, 2018
A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
Ciara M Kelly, Alexander N Shoushtari, Li-Xuan Qin, et al.
The Journal of Clinical Investigation
|
January 24, 2018
COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors
Yuanyuan Xie, Zhen Cao, Elissa Wp Wong, et al.
The Oncologist
|
July 27, 2021
Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study
John R Zalcberg, Michael C Heinrich, Suzanne George, et al.
The Lancet. Oncology
|
July 8, 2024
Interpretable artificial intelligence to optimise use of imatinib after resection in patients with localised gastrointestinal stromal tumours: an observational cohort study
Dimitris Bertsimas, Georgios Antonios Margonis, Suleeporn Sujichantararat, et al.
Science Advances
|
April 5, 2023
ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer
Dan Li, Yu Zhan, Naitao Wang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
September 7, 2024
Comprehensive genomic profiling in multiple cancer types: A comparative analysis of the National Biobank Consortium of Taiwan and clinical practice cohorts
Ling-Jen Hung, Chen-Yang Huang, Kai-Che Tung, et al.
The Journal of Clinical Investigation
|
June 24, 2025
BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature-positive castration-resistant prostate cancer
Shipra Shukla, Dan Li, Woo Hyun Cho, et al.
Cancer Discovery
|
December 15, 2020
SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies
Mahesh Saqcena, Luis Javier Leandro-Garcia, Jesper L V Maag, et al.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
Cell-Autonomous AR Dependence in Luminal Prostatic Epithelium Governs Survival and Lineage Plasticity
Dan Li, Naitao Wang, Wangxin Guo, et al.
Page
of 27